The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition
Open accessAbstract
Summary Background The Global Burden of Disease Study 2013 (GBD 2013) aims to bring together all available epidemiological data using a coherent measurement framework, standardised estimation methods, and transparent data sources to enable comparisons of health loss over time and across causes, age–sex groups, and countries. The GBD can be used to generate summary measures such as disability-adjusted life-years (DALYs) and healthy life expectancy (HALE) that make possible comparative assessments of broad epidemiological patterns across countries and time. These summary measures can also be used to quantify the component of variation in epidemiology that is related to sociodemographic development. Methods We used the published GBD 2013 data for age-specific mortality, years of life lost due to premature mortality (YLLs), and years lived with disability (YLDs) to calculate DALYs and HALE for 1990, 1995, 2000, 2005, 2010, and 2013 for 188 countries. We calculated HALE using the Sullivan method; 95% uncertainty intervals (UIs) represent uncertainty in age-specific death rates and YLDs per person for each country, age, sex, and year. We estimated DALYs for 306 causes for each country as the sum of YLLs and YLDs; 95% UIs represent uncertainty in YLL and YLD rates. We quantified patterns of the epidemiological transition with a composite indicator of sociodemographic status, which we constructed from income per person, average years of schooling after age 15 years, and the total fertility rate and mean age of the population. We applied hierarchical regression to DALY rates by cause across countries to decompose variance related to the sociodemographic status variable, country, and time. Findings Worldwide, from 1990 to 2013, life expectancy at birth rose by 6·2 years (95% UI 5·6–6·6), from 65·3 years (65·0–65·6) in 1990 to 71·5 years (71·0–71·9) in 2013, HALE at birth rose by 5·4 years (4·9–5·8), from 56·9 years (54·5–59·1) to 62·3 years (59·7–64·8), total DALYs fell by 3·6% (0·3–7·4), and age-standardised DALY rates per 100 000 people fell by 26·7% (24·6–29·1). For communicable, maternal, neonatal, and nutritional disorders, global DALY numbers, crude rates, and age-standardised rates have all declined between 1990 and 2013, whereas for non–communicable diseases, global DALYs have been increasing, DALY rates have remained nearly constant, and age-standardised DALY rates declined during the same period. From 2005 to 2013, the number of DALYs increased for most specific non-communicable diseases, including cardiovascular diseases and neoplasms, in addition to dengue, food-borne trematodes, and leishmaniasis; DALYs decreased for nearly all other causes. By 2013, the five leading causes of DALYs were ischaemic heart disease, lower respiratory infections, cerebrovascular disease, low back and neck pain, and road injuries. Sociodemographic status explained more than 50% of the variance between countries and over time for diarrhoea, lower respiratory infections, and other common infectious diseases; maternal disorders; neonatal disorders; nutritional deficiencies; other communicable, maternal, neonatal, and nutritional diseases; musculoskeletal disorders; and other non-communicable diseases. However, sociodemographic status explained less than 10% of the variance in DALY rates for cardiovascular diseases; chronic respiratory diseases; cirrhosis; diabetes, urogenital, blood, and endocrine diseases; unintentional injuries; and self-harm and interpersonal violence. Predictably, increased sociodemographic status was associated with a shift in burden from YLLs to YLDs, driven by declines in YLLs and increases in YLDs from musculoskeletal disorders, neurological disorders, and mental and substance use disorders. In most country-specific estimates, the increase in life expectancy was greater than that in HALE. Leading causes of DALYs are highly variable across countries. Interpretation Global health is improving. Population growth and ageing have driven up numbers of DALYs, but crude rates have remained relatively constant, showing that progress in health does not mean fewer demands on health systems. The notion of an epidemiological transition—in which increasing sociodemographic status brings structured change in disease burden—is useful, but there is tremendous variation in burden of disease that is not associated with sociodemographic status. This further underscores the need for country-specific assessments of DALYs and HALE to appropriately inform health policy decisions and attendant actions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888
Self-citationSalomon, J. A., Wang, H., Freeman, M. K., Vos, T., Flaxman, A. D., Lopez, A. D., & Murray, C. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61690-0 · Cited by 1,116
Self-citationGBD 2010: design, definitions, and metrics
Murray, C. J., Ezzati, M., Flaxman, A. D., Lim, S., Lozano, R., Michaud, C., Naghavi, M., Salomon, J. A., Shibuya, K., Vos, T., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61899-6 · Cited by 1,103
Self-citationModeling causes of death: an integrated approach using CODEm
Foreman, K. J., Lozano, R., Lopez, A. D., & Murray, C. J. (2012) · Population Health Metrics · doi:10.1186/1478-7954-10-1 · Cited by 564
Self-citationThe Anatomy of Medical Research: US and International Comparisons
Moses, H., Matheson, D. H. M., Cairns-Smith, S., George, B. P., Palisch, C., & Dorsey, E. R. (2015) · JAMA · doi:10.1001/jama.2014.15939 · Cited by 446
Research works printed but not linked: 47
- 2015, Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013, Lancet, 386, 743, 10.1016/S0140-6736(15)60692-4 · DOI · Paper page
- 2014, Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013, Lancet, 385, 117
- Murray, 2000, A critical examination of summary measures of population health, Bull World Health Organ, 78, 981
- Santosa, 2014, The development and experience of epidemiological transition theory over four decades: a systematic review, Glob Health Action, 7, 23574, 10.3402/gha.v7.23574 · DOI
- Murray, 2014, Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013, Lancet, 384, 1005, 10.1016/S0140-6736(14)60844-8 · DOI · Paper page
- Hill, 2007, Epidemiologic transition interrupted: a reassessment of mortality trends in Thailand, 1980–2000, Int J Epidemiol, 36, 374, 10.1093/ije/dyl257 · DOI
- Hofmarcher, 1998, Is public health between East and West? Analysis of wealth, health and mortality in Austria, Central and Eastern European Countries and Croatia relative to the European Union, Croat Med J, 39, 241
- Kahn, 2007, Mortality trends in a new South Africa: hard to make a fresh start, Scand J Public Health Suppl, 69, 26, 10.1080/14034950701355668 · DOI
- Rivera, 2002, Epidemiological and nutritional transition in Mexico: rapid increase of non-communicable chronic diseases and obesity, Public Health Nutr, 5, 113, 10.1079/PHN2001282 · DOI · Paper page
- Yang, 2008, Emergence of chronic non-communicable diseases in China, Lancet, 372, 1697, 10.1016/S0140-6736(08)61366-5 · DOI · Paper page
- Yang, 2013, Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010, Lancet, 381, 1987, 10.1016/S0140-6736(13)61097-1 · DOI · Paper page
- Salomon, 2012, Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010, Lancet, 380, 2129, 10.1016/S0140-6736(12)61680-8 · DOI · Paper page
- Sullivan, 1971, A single index of mortality and morbidity, HSMHA Health Rep, 86, 347, 10.2307/4594169 · DOI · Paper page
- Bloom, 2000, Policy forum: public health. The health and wealth of nations, Science, 287, 1207, 10.1126/science.287.5456.1207 · DOI · Paper page
- Preston, 1975, The changing relation between mortality and level of economic development, Popul Stud (Camb), 29, 231, 10.1080/00324728.1975.10410201 · DOI · Paper page
- Gelman, 2005, Analysis of variance—why it is more important than ever, Ann Stat, 33, 1, 10.1214/009053604000001048 · DOI · Paper page
- Omran, 1971, The epidemiologic transition. A theory of the epidemiology of population change, Milbank Mem Fund Q, 49, 509, 10.2307/3349375 · DOI · Paper page
- Agyei-Mensah, 2010, Epidemiological transition and the double burden of disease in Accra, Ghana, J Urban Health, 87, 879, 10.1007/s11524-010-9492-y · DOI · Paper page
- Frenk, 1991, Elements for a theory of the health transition, Health Transit Rev, 1, 21
- Andreev, 2003, The evolving pattern of avoidable mortality in Russia, Int J Epidemil, 32, 437, 10.1093/ije/dyg085 · DOI
- McMichael, 2004, Mortality trends and setbacks: global convergence or divergence?, Lancet, 363, 1155, 10.1016/S0140-6736(04)15902-3 · DOI
- Smallman-Raynor, 1999, Late stages of epidemiological transition: health status in the developed world, Health Place, 5, 209, 10.1016/S1353-8292(99)00010-6 · DOI
- Carolina Martínez, 2003, Epidemiological transition: model or illusion? A look at the problem of health in Mexico, Soc Sci Med, 57, 539, 10.1016/S0277-9536(02)00379-9 · DOI
- Caselli, 2002, Epidemiologic transition theory exceptions, Genus, 58, 9
- Rivera-Andrade, 2014, Trends and heterogeneity of cardiovascular disease and risk factors across Latin American and Caribbean countries, Prog Cardiovasc Dis, 57, 276, 10.1016/j.pcad.2014.09.004 · DOI
- Bloom, 2007, Commentary: The Preston Curve 30 years on: still sparking fires, Int J Epidemiol, 36, 498, 10.1093/ije/dym079 · DOI
- Mackenbach, 2013, Life expectancy and national income in Europe, 1900–2008: an update of Preston's analysis, Int J Epidemiol, 42, 1100, 10.1093/ije/dyt122 · DOI
- Preston, 2007, The changing relation between mortality and level of economic development. Population Studies, Vol. 29, No. 2, July 1975, Int J Epidemiol, 36, 484, 10.1093/ije/dym075 · DOI
- Bergström, 2015, Low socioeconomic status of a patient's residential area is associated with worse prognosis after acute myocardial infarction in Sweden, Int J Cardiol, 182, 141, 10.1016/j.ijcard.2014.12.060 · DOI
- Capingana, 2013, Prevalence of cardiovascular risk factors and socioeconomic level among public-sector workers in Angola, BMC Public Health, 13, 732, 10.1186/1471-2458-13-732 · DOI
- Chang, 2014, Clinical and socioeconomic factors associated with unrecognized peripheral artery disease, Vasc Med, 19, 289, 10.1177/1358863X14535475 · DOI
- Di Cesare, 2013, Inequalities in non-communicable diseases and effective responses, Lancet, 381, 585, 10.1016/S0140-6736(12)61851-0 · DOI · Paper page
- Marmot, 1987, Social/economic status and disease, Annu Rev Public Health, 8, 111, 10.1146/annurev.pu.08.050187.000551 · DOI · Paper page
- Marmot, 1984, Inequalities in death—specific explanations of a general pattern?, Lancet, 1, 1003, 10.1016/S0140-6736(84)92337-7 · DOI · Paper page
- Marmot, 1991, Health inequalities among British civil servants: the Whitehall II study, Lancet, 337, 1387, 10.1016/0140-6736(91)93068-K · DOI · Paper page
- Wang, 2014, Low socioeconomic status increases short-term mortality of acute myocardial infarction despite universal health coverage, Int J Cardiol, 172, 82, 10.1016/j.ijcard.2013.12.082 · DOI
- Wu, 2013, Lower socioeconomic status is associated with worse outcomes in pulmonary arterial hypertension, Am J Respir Crit Care Med, 187, 303, 10.1164/rccm.201207-1290OC · DOI
- Jagger, 2008, Inequalities in healthy life years in the 25 countries of the European Union in 2005: a cross-national meta-regression analysis, Lancet, 372, 2124, 10.1016/S0140-6736(08)61594-9 · DOI · Paper page
- King, 2004, Enhancing the validity and cross-cultural comparability of measurement in survey research, Am Polit Sci Rev, 98, 191, 10.1017/S000305540400108X · DOI · Paper page
- Salomon, 2009, Are Americans feeling less healthy? The puzzle of trends in self-rated health, Am J Epidemiol, 170, 343, 10.1093/aje/kwp144 · DOI
- Salomon, 2004, Comparability of self rated health: cross sectional multi-country survey using anchoring vignettes, BMJ, 328, 258, 10.1136/bmj.37963.691632.44 · DOI · Paper page
- Gennaro, 2012, In Italy, healthy life expectancy drop dramatically: from 2004 to 2008 there was a 10 years drop among newborn girls, Ital J Pediatr, 38, 19, 10.1186/1824-7288-38-19 · DOI
- Catalá-López, 2010, Does the development of new medicinal products in the European Union address global and regional health concerns?, Popul Health Metr, 8, 34, 10.1186/1478-7954-8-34 · DOI
- Dorsey, 2009, Financing of U.S. biomedical research and new drug approvals across therapeutic areas, PLoS One, 4, e7015, 10.1371/journal.pone.0007015 · DOI
- Gross, 1999, The relation between funding by the National Institutes of Health and the burden of disease, N Engl J Med, 340, 1881, 10.1056/NEJM199906173402406 · DOI · Paper page
- Keyhani, 2010, US pharmaceutical innovation in an international context, Am J Public Health, 100, 1075, 10.2105/AJPH.2009.178491 · DOI
- Luengo-Fernandez, 2012, UK research expenditure on dementia, heart disease, stroke and cancer: are levels of spending related to disease burden?, Eur J Neurol, 19, 149, 10.1111/j.1468-1331.2011.03500.x · DOI
Cited by
Vos, T., Allen, C., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31678-6 · Cited by 7,253
Self-citationWang, H., Naghavi, M., Allen, C., Barber, R. M., Bhutta, Z. A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., Coates, M. M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31012-1 · Cited by 6,596
Self-citationWhat low back pain is and why we need to pay attention
Hartvigsen, J., Hancock, M. J., Kongsted, A., Louw, Q., Ferreira, M. L., Genevay, S., Hoy, D., Karppinen, J., Pransky, G., Sieper, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30480-x · Cited by 4,652
Self-citationOur future: a Lancet commission on adolescent health and wellbeing
Patton, G. C., Sawyer, S. M., Santelli, J. S., Ross, D. A., Afifi, R., Allen, N. B., Arora, M., Azzopardi, P., Baldwin, W., Bonell, C., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00579-1 · Cited by 3,785
Self-citationCipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., Leucht, S., Ruhe, H. G., Turner, E. H., Higgins, J. P. T., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32802-7 · Cited by 3,541
Metadata
- Authors
- Murray, C. J. L., Barber, R. M., Foreman, K. J., Ozgoren, A. A., Abd-Allah, F., Abera, S. F., Aboyans, V., Abraham, J. P., Abubakar, I., Abu-Raddad, L. J., Abu-Rmeileh, N. M., Achoki, T., Ackerman, I. N., Ademi, Z., Adou, A. K., Adsuar, J. C., Afshin, A., Agardh, E. E., Alam, S. S., Alasfoor, D., Albittar, M. I., Alegretti, M. A., Alemu, Z. A., Alfonso-Cristancho, R., Alhabib, S., Ali, R., Alla, F., Allebeck, P., Almazroa, M. A., Alsharif, U., Alvarez, E., Alvis-Guzman, N., Amare, A. T., Ameh, E. A., Amini, H., Ammar, W., Anderson, H. R., Anderson, B. O., Antonio, C. A. T., Anwari, P., Arnlöv, J., Arsenijevic, V. S. A., Artaman, A., Asghar, R. J., Assadi, R., Atkins, L. S., Avila, M. A., Awuah, B., Bachman, V. F., Badawi, A., Bahit, M. C., Balakrishnan, K., Banerjee, A., Barker-Collo, S. L., Barquera, S., Barregard, L., Barrero, L. H., Basu, A., Basu, S., Basulaiman, M. O., Beardsley, J., Bedi, N., Beghi, E., Bekele, T., Bell, M. L., Benjet, C., Bennett, D. A., Bensenor, I. M., Benzian, H., Bernabé, E., Bertozzi-Villa, A., Beyene, T. J., Bhala, N., Bhalla, A., Bhutta, Z. A., Bienhoff, K., Bikbov, B., Biryukov, S., Blore, J. D., Blosser, C. D., Blyth, F. M., Bohensky, M. A., Bolliger, I. W., Başara, B. B., Bornstein, N. M., Bose, D., Boufous, S., Bourne, R. R. A., Boyers, L. N., Brainin, M., Brayne, C. E., Brazinova, A., Breitborde, N. J. K., Brenner, H., Briggs, A. D., Brooks, P. M., Brown, J. C., Brugha, T. S., Buchbinder, R., Buckle, G. C., Budke, C. M., Bulchis, A., Bulloch, A. G., Campos-Nonato, I. R., Carabin, H., Carapetis, J. R., Cárdenas, R., Carpenter, D. O., Caso, V., Castañeda-Orjuela, C. A., Castro, R. E., Catalá-López, F., Cavalleri, F., Çavlin, A., Chadha, V. K., Chang, J.-C., Charlson, F. J., Chen, H., Chen, W., Chiang, P. P., Chimed-Ochir, O., Chowdhury, R., Christensen, H., Christophi, C. A., Cirillo, M., Coates, M. M., Coffeng, L. E., Coggeshall, M. S., Colistro, V., Colquhoun, S. M., Cooke, G. S., Cooper, C., Cooper, L. T., Coppola, L. M., Cortinovis, M., Criqui, M. H., Crump, J. A., Cuevas-Nasu, L., Danawi, H., Dandona, L., Dandona, R., Dansereau, E., Dargan, P. I., Davey, G., Davis, A., Davitoiu, D. V., Dayama, A., De Leo, D., Degenhardt, L., Del Pozo-Cruz, B., Dellavalle, R. P., Deribe, K., Derrett, S., Jarlais, D. C. D., Dessalegn, M., Dharmaratne, S. D., Dherani, M. K., Diaz-Torné, C., Dicker, D., Ding, E. L., Dokova, K., Dorsey, E. R., Driscoll, T. R., Duan, L., Duber, H. C., Ebel, B. E., Edmond, K. M., Elshrek, Y. M., Endres, M., Ermakov, S. P., Erskine, H. E., Eshrati, B., Esteghamati, A., Estep, K., Faraon, E. J. A., Farzadfar, F., Fay, D. F., Feigin, V. L., Felson, D. T., Fereshtehnejad, S.-M., Fernandes, J. G., Ferrari, A. J., Fitzmaurice, C., Flaxman, A. D., Fleming, T. D., Foigt, N., Forouzanfar, M. H., Fowkes, F. G. R., Paleo, U. F., Franklin, R. C., Fürst, T., Gabbe, B., Gaffikin, L., Gankpé, F. G., Geleijnse, J. M., Gessner, B. D., Gething, P., Gibney, K. B., Giroud, M., Giussani, G., Dantes, H. G., Gona, P., González-Medina, D., Gosselin, R. A., Gotay, C. C., Goto, A., Gouda, H. N., Graetz, N., Gugnani, H. C., Gupta, R., Gupta, R., Gutiérrez, R. A., Haagsma, J., Hafezi-Nejad, N., Hagan, H., Halasa, Y. A., Hamadeh, R. R., Hamavid, H., Hammami, M., Hancock, J., Hankey, G. J., Hansen, G. M., Hao, Y., Harb, H. L., Haro, J. M., Havmoeller, R., Hay, S. I., Hay, R. J., Heredia-Pi, I. B., Heuton, K. R., Heydarpour, P., Higashi, H., Hijar, M., Hoek, H. W., Hoffman, H. J., Hosgood, H. D., Hossain, M., Hotez, P. J., Hoy, D. G., Hsairi, M., Hu, G., Huang, C., Huang, J. J., Husseini, A., Huynh, C., Iannarone, M. L., Iburg, K. M., Innos, K., Inoue, M., Islami, F., Jacobsen, K. H., Jarvis, D. L., Jassal, S. K., Jee, S. H., Jeemon, P., Jensen, P. N., Jha, V., Jiang, G., Jiang, Y., Jonas, J. B., Juel, K., Kan, H., Karch, A., Karema, C. K., Karimkhani, C., Karthikeyan, G., Kassebaum, N. J., Kaul, A., Kawakami, N., Kazanjan, K., Kemp, A. H., Kengne, A. P., Keren, A., Khader, Y. S., Khalifa, S. E. A., Khan, E. A., Khan, G., Khang, Y.-H., Kieling, C., Kim, D., Kim, S., Kim, Y., Kinfu, Y., Kinge, J. M., Kivipelto, M., Knibbs, L. D., Knudsen, A. K., Kokubo, Y., Kosen, S., Krishnaswami, S., Defo, B. K., Bicer, B. K., Kuipers, E. J., Kulkarni, C., Kulkarni, V. S., Kumar, G. A., Kyu, H. H., Lai, T., Lalloo, R., Lallukka, T., Lam, H., Lan, Q., Lansingh, V. C., Larsson, A., Lawrynowicz, A. E. B., Leasher, J. L., Leigh, J., Leung, R., Levitz, C. E., Li, B., Li, Y., Li, Y., Lim, S. S., Lind, M., Lipshultz, S. E., Liu, S., Liu, Y., Lloyd, B. K., Lofgren, K. T., Logroscino, G., Looker, K. J., Lortet-Tieulent, J., Lotufo, P. A., Lozano, R., Lucas, R. M., Lunevicius, R., Lyons, R. A., Ma, S., Macintyre, M. F., Mackay, M. T., Majdan, M., Malekzadeh, R., Marcenes, W., Margolis, D. J., Margono, C., Marzan, M. B., Masci, J. R., Mashal, M. T., Matzopoulos, R., Mayosi, B. M., Mazorodze, T. T., Mcgill, N. W., Mcgrath, J. J., Mckee, M., Mclain, A., Meaney, P. A., Medina, C., Mehndiratta, M. M., Mekonnen, W., Melaku, Y. A., Meltzer, M., Memish, Z. A., Mensah, G. A., Meretoja, A., Mhimbira, F. A., Micha, R., Miller, T. R., Mills, E. J., Mitchell, P. B., Mock, C. N., Ibrahim, N. M., Mohammad, K. A., Mokdad, A. H., Mola, G. L. D., Monasta, L., Hernandez, J. C. M., Montico, M., Montine, T. J., Mooney, M. D., Moore, A. R., Moradi-Lakeh, M., Moran, A. E., Mori, R., Moschandreas, J., Moturi, W. N., Moyer, M. L., Mozaffarian, D., Msemburi, W. T., Mueller, U. O., Mukaigawara, M., Mullany, E. C., Murdoch, M. E., Murray, J., Murthy, K. S., Naghavi, M., Naheed, A., Naidoo, K. S., Naldi, L., Nand, D., Nangia, V., Narayan, K. M. V., Nejjari, C., Neupane, S. P., Newton, C. R., Ng, M., Ngalesoni, F. N., Nguyen, G., Nisar, M. I., Nolte, S., Norheim, O. F., Norman, R. E., Norrving, B., Nyakarahuka, L., Oh, I.-H., Ohkubo, T., Ohno, S. L., Olusanya, B. O., Opio, J. N., Ortblad, K., Ortiz, A., Pain, A. W., Pandian, J. D., Panelo, C. I. A., Papachristou, C., Park, E.-K., Park, J.-H., Patten, S. B., Patton, G. C., Paul, V. K., Pavlin, B. I., Pearce, N., Pereira, D. M., Perez-Padilla, R., Perez-Ruiz, F., Perico, N., Pervaiz, A., Pesudovs, K., Peterson, C. B., Petzold, M., Phillips, M. R., Phillips, B. K., Phillips, D. E., Piel, F. B., Plass, D., Poenaru, D., Polinder, S., Pope, D., Popova, S., Poulton, R. G., Pourmalek, F., Prabhakaran, D., Prasad, N. M., Pullan, R. L., Qato, D. M., Quistberg, D. A., Rafay, A., Rahimi, K., Rahman, S. U., Raju, M., Rana, S. M., Razavi, H., Reddy, K. S., Refaat, A., Remuzzi, G., Resnikoff, S., Ribeiro, A. L., Richardson, L., Richardus, J. H., Roberts, D. A., Rojas-Rueda, D., Ronfani, L., Roth, G. A., Rothenbacher, D., Rothstein, D. H., Rowley, J. T., Roy, N., Ruhago, G. M., Saeedi, M. Y., Saha, S., Sahraian, M. A., Sampson, U. K. A., Sanabria, J. R., Sandar, L., Santos, I. S., Satpathy, M., Sawhney, M., Scarborough, P., Schneider, I. J., Schöttker, B., Schumacher, A. E., Schwebel, D. C., Scott, J. G., Seedat, S., Sepanlou, S. G., Serina, P. T., Servan-Mori, E. E., Shackelford, K. A., Shaheen, A., Shahraz, S., Levy, T. S., Shangguan, S., She, J., Sheikhbahaei, S., Shi, P., Shibuya, K., Shinohara, Y., Shiri, R., Shishani, K., Shiue, I., Shrime, M. G., Sigfusdottir, I. D., Silberberg, D. H., Simard, E. P., Sindi, S., Singh, A., Singh, J. A., Singh, L., Skirbekk, V., Slepak, E. L., Sliwa, K., Soneji, S., Søreide, K., Soshnikov, S., Sposato, L. A., Sreeramareddy, C. T., Stanaway, J. D., Stathopoulou, V., Stein, D. J., Stein, M. B., Steiner, C., Steiner, T. J., Stevens, A., Stewart, A., Stovner, L. J., Stroumpoulis, K., Sunguya, B. F., Swaminathan, S., Swaroop, M., Sykes, B. L., Tabb, K. M., Takahashi, K., Tandon, N., Tanne, D., Tanner, M., Tavakkoli, M., Taylor, H. R., Ao, B. J. T., Tediosi, F., Temesgen, A. M., Templin, T., Ten Have, M., Tenkorang, E. Y., Terkawi, A. S., Thomson, B., Thorne-Lyman, A. L., Thrift, A. G., Thurston, G. D., Tillmann, T., Tonelli, M., Topouzis, F., Toyoshima, H., Traebert, J., Tran, B. X., Trillini, M., Truelsen, T., Tsilimbaris, M., Tuzcu, E. M., Uchendu, U. S., Ukwaja, K. N., Undurraga, E. A., Uzun, S. B., Van Brakel, W. H., Van De Vijver, S., van Gool, C. H., Van Os, J., Vasankari, T. J., Venketasubramanian, N., Violante, F. S., Vlassov, V. V., Vollset, S. E., Wagner, G. R., Wagner, J., Waller, S. G., Wan, X., Wang, H., Wang, J., Wang, L., Warouw, T. S., Weichenthal, S., Weiderpass, E., Weintraub, R. G., Wenzhi, W., Werdecker, A., Westerman, R., Whiteford, H. A., Wilkinson, J. D., Williams, T. N., Wolfe, C. D., Wolock, T. M., Woolf, A. D., Wulf, S., Wurtz, B., Xu, G., Yan, L. L., Yano, Y., Ye, P., Yentür, G. K., Yip, P., Yonemoto, N., Yoon, S.-J., Younis, M. Z., Yu, C., Zaki, M. E., Zhao, Y., Zheng, Y., Zonies, D., Zou, X., Salomon, J. A., Lopez, A. D., & Vos, T.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2015-11
- Volume
- 386
- Issue
- 10009
- Pages
- 2145-2191
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2142472354
- Cited by
- 1,964
- References
- 5
- FWCI
- 724.72
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- Wellcome Trust Fellowship in Public Health and Tropical Medicine (grant number 099876)
- National Natural Science Foundation for Young Scholars of China (number 81200051)
- Science Foundation for Young Scholars in Zhongshan Hospital (number 2012ZSQN04)
- Scientific Project for Fudan University (number 20520133474)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.